National Institute for Occupational Safety and Health (NIOSH), Safety and Occupational Health Study Section (SOHSS), 56549 [2010-23101]
Download as PDF
<![CDATA[
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 75, No. 179 / Thursday, September 16, 2010 / Notices
Administration, 10903 New Hampshire
Ave., Bldg. 31, rm. 2417, Silver Spring,
MD 20993–0002, 301–796–9001, FAX:
301–847–8533, email:
diem.ngo@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), codes
3014512543 and 3014512535. Please
call the Information Line for up-to-date
information on this meeting. A notice in
the Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
agency’s Web site and call the
appropriate advisory committee hot
line/phone line to learn about possible
modifications before coming to the
meeting.
Agenda: On November 3, 2010, the
committees will discuss a number of
safety concerns with intravenous
administration of the anti-seizure drugs
phenytoin and fosphenytoin, including
the condition known as Purple Glove
Syndrome, and recommend what
regulatory actions, if any, are necessary
to diminish the risks.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before October 20, 2010.
Oral presentations from the public will
be scheduled between approximately 1
p.m. and 2 p.m. Those desiring to make
formal oral presentations should notify
the contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before October 12, 2010. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
VerDate Mar<15>2010
19:19 Sep 15, 2010
Jkt 220001
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
October 13, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Diem-Kieu
Ngo at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: September 10, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–23044 Filed 9–15–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health (NIOSH), Safety and
Occupational Health Study Section
(SOHSS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Times and Dates:
8 a.m.–5 p.m., October 7, 2010 (Closed);
8 a.m.–5 p.m., October 8, 2010 (Closed).
Place: Embassy Suites Hotel, 1900
Diagonal Road, Alexandria, Virginia,
22314, Telephone (703) 684–5900, Fax
(703) 684–1403.
Purpose: The Safety and Occupational
Health Study Section will review,
discuss, and evaluate grant
application(s) received in response to
the Institute’s standard grants review
and funding cycles pertaining to
research issues in occupational safety
and health, and allied areas.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
56549
It is the intent of NIOSH to support
broad-based research endeavors in
keeping with the Institute’s program
goals. This will lead to improved
understanding and appreciation for the
magnitude of the aggregate health
burden associated with occupational
injuries and illnesses, as well as to
support more focused research projects,
which will lead to improvements in the
delivery of occupational safety and
health services, and the prevention of
work-related injury and illness. It is
anticipated that research funded will
promote these program goals.
Matters to be Discussed: The meeting
agenda includes discussions on matters
related to the conduct of Study Section
business and for the study section to
consider safety and occupational healthrelated grant applications. These
portions of the meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, Centers for Disease Control and
Prevention, pursuant to Section 10(d)
Public Law 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Price Connor, PhD, NIOSH Health
Scientist, 1600 Clifton Road, NE.,
Mailstop E–20, Atlanta, Georgia 30333,
Telephone (404) 498–2511, Fax (404)
498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: September 10, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention .
[FR Doc. 2010–23101 Filed 9–15–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff,
Announces the Following Meeting
Name: ICD–9–CM Coordination and
Maintenance Committee meeting.
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 75, Number 179 (Thursday, September 16, 2010)]
[Notices]
[Page 56549]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-23101]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH),
Safety and Occupational Health Study Section (SOHSS)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Times and Dates:
8 a.m.-5 p.m., October 7, 2010 (Closed);
8 a.m.-5 p.m., October 8, 2010 (Closed).
Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria,
Virginia, 22314, Telephone (703) 684-5900, Fax (703) 684-1403.
Purpose: The Safety and Occupational Health Study Section will
review, discuss, and evaluate grant application(s) received in response
to the Institute's standard grants review and funding cycles pertaining
to research issues in occupational safety and health, and allied areas.
It is the intent of NIOSH to support broad-based research endeavors
in keeping with the Institute's program goals. This will lead to
improved understanding and appreciation for the magnitude of the
aggregate health burden associated with occupational injuries and
illnesses, as well as to support more focused research projects, which
will lead to improvements in the delivery of occupational safety and
health services, and the prevention of work-related injury and illness.
It is anticipated that research funded will promote these program
goals.
Matters to be Discussed: The meeting agenda includes discussions on
matters related to the conduct of Study Section business and for the
study section to consider safety and occupational health-related grant
applications. These portions of the meeting will be closed to the
public in accordance with provisions set forth in Section 552b(c)(4)
and (6), Title 5 U.S.C., and the Determination of the Director,
Management Analysis and Services Office, Centers for Disease Control
and Prevention, pursuant to Section 10(d) Public Law 92-463.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Price Connor, PhD, NIOSH
Health Scientist, 1600 Clifton Road, NE., Mailstop E-20, Atlanta,
Georgia 30333, Telephone (404) 498-2511, Fax (404) 498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: September 10, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention .
[FR Doc. 2010-23101 Filed 9-15-10; 8:45 am]
BILLING CODE 4163-18-P
